Teva wins FDA approval for monthly schizophrenia injection Weltruza

Teva said on Friday it ​had received approval ‌from the US Food and Drug ​Administration for ​its Weltruza drug for ⁠extended-release injectable suspension ​as the first ​and only once-monthly subcuta...

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。